StonvexLoading…
StonvexStonvexStonvexCore line items from CG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $254.00M | $4.78B | $2.88B | $2.55B |
Operating Income | $-179.00M | $1.16B | $697.40M | $611.60M |
Net Income | $-132.20M | $808.70M | $450.60M | $449.70M |
EPS (Diluted) | $-0.37 | $2.18 | $1.22 | $1.23 |
Total Assets | $29.84B | $29.12B | $27.06B | $25.07B |
Total Liabilities | $22.47B | $22.06B | $20.21B | $18.35B |
Cash & Equivalents | $1.67B | $1.97B | $2.22B | $1.28B |
Free Cash Flow OCF − CapEx | $-1.27B | $-3.37B | $-2.14B | $-555.10M |
Shares Outstanding | 359.84M | 357.37M | 360.14M | 358.96M |